Table 3 Tumour type treated with anthracyclines

From: Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy

 

No. of patients with the tumour type

No. of patients treated with anthracyclines

Breast cancers

39

22 (56%)

Lymphomas

12

10 (83%)

Gastrointestinal cancers

29

0

Head and neck cancers

17

0

Lung cancers

13

0

Other cancers

18

9 (50%)